FDA approves generic enoxaparin sodium for US sale
Click Here to Manage Email Alerts
Techdow USA announced the FDA approval of its generic enoxaparin sodium for marketing in the U.S.
The preservative-free anticoagulant, used to prevent and treat deep vein thrombosis, will be available in prefilled syringes, according to a company press release.
“Techdow USA is excited to bring this critical product to institutions, retail and other networks in need of a safe, affordable and reliable source of Enoxaparin,” Darren Alkins, CEO of Techdow USA, said in the release. “As a vertically integrated company in this complex environment with difficult to source raw material and state-of-the-art prefilled syringe manufacturing, our U.S. and global networks will help ensure reliable enoxaparin supply, while offering competitive pricing.”
Collapse
Read more about
Click Here to Manage Email Alerts